middle.news
How Starpharma’s Genentech Deal Sparked a $1.37 Million Profit Turnaround
8:46am on Wednesday 18th of February, 2026 AEDT
•
Biotechnology
Read Story
How Starpharma’s Genentech Deal Sparked a $1.37 Million Profit Turnaround
8:46am on Wednesday 18th of February, 2026 AEDT
Key Points
H1 FY26 revenue surged 474% to $10.8 million, boosted by $8.34 million Genentech upfront payment
Starpharma posts $1.37 million profit, reversing prior period $5.39 million loss
DEP® HER2 radiopharmaceutical program advancing towards first-in-patient trial in 2026
New research and option agreement signed with Radiopharm Theranostics
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
STARPHARMA HOLDINGS (ASX:SPL)
OPEN ARTICLE